Smoking and the outcome of infection

Journal of Internal Medicine

Volumn 269, Issue 3, 2011, Pages 258-269

  Huttunen, R ^a,b   Heikkinen, T ^c   Syrjanen J ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bacteraemia; Environmental smoke exposure; Infection; Outcome; Pneumonia; Smoking; Tobacco

Indexed keywords

ANTIRETROVIRUS AGENT; TOBACCO SMOKE;

ALCOHOL ABUSE; ALCOHOLISM; BACTEREMIA; BACTERIAL PNEUMONIA; BRONCHITIS; COCCIDIOIDOMYCOSIS; COMMON COLD; DISEASE SEVERITY; DRUG ABUSE; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GLUCOSE INTOLERANCE; HAIRY LEUKOPLAKIA; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFLUENZA; INVASIVE PNEUMOCOCCAL DISEASE; LOWER RESPIRATORY TRACT INFECTION; MENINGOCOCCOSIS; MYCOSIS; NONHUMAN; OUTCOME ASSESSMENT; PERIODONTITIS; PNEUMOCOCCAL INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPSIS; SEXUAL BEHAVIOR; SMOKING; SMOKING HABIT; SOCIOECONOMICS; SURGICAL INFECTION; THRUSH; TUBERCULOSIS;

ADULT; CHILD; DISEASE SUSCEPTIBILITY; HUMANS; INFECTION; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 79951743235     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02332.x     Document Type: Review

References (136)

1. Zarocostas J. Twenty four risk factors responsible for nearly half of annual deaths, says WHO. BMJ 2009; 339: b4439.
2. Nuorti JP, Butler JC, Farley MM et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342: 681-9.
3. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000; 160: 3082-8.
4. Kark JD, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N Engl J Med 1982; 307: 1042-6.
5. Bergstrom J. Tobacco smoking and chronic destructive periodontal disease. Odontology 2004; 92: 1-8.
6. Fischer M, Hedberg K, Cardosi P et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J 1997; 16: 979-83.
7. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 335-42.
8. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007; 4: e20.
9. Cayci C, Russo M, Cheema F et al. Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg 2008; 61: 294-301.
10. Steingrimsson S, Gottfredsson M, Kristinsson KG, Gudbjartsson T. Deep sternal wound infections following open heart surgery in Iceland: a population-based study. Scand Cardiovasc J 2008; 42: 208-13.
11. Farinas MC, Gald Peralta F, Bernal JM, Rabasa JM, Revuelta JM, Gonzalez-Macias J. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 1995; 20: 272-9.
12. Kalin M, Ortqvist A, Almela M et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 2000; 182: 840-7.
13. Laurichesse H, Romaszko JP, Nguyen LT et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994-1998. Eur J Clin Microbiol Infect Dis 2001; 20: 299-308.
14. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2): S27-72.
15. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009. Ann Intern Med 2009; 150: 40-4.
16. Centers for Disease Control and Prevention. State specific prevalence of cigarette smoking and quitting among adults- United States, 2004. MMWR 2005; 54: 1124-7.
17. Pearson WS, Dube SR, Ford ES, Mokdad AH. Influenza and pneumococcal vaccination rates among smokers: data from the 2006 Behavioral Risk Factor Surveillance System. Prev Med 2009; 48: 180-3.
18. Centers for Disease Control and Prevention (CDC). Cigarette smoking-attributable mortality and years of potential life lost-United States, 1990. MMWR Morb Mortal Wkly Rep 1993; 42: 645-9.
19. Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA 2000; 284: 706-12.
20. Correa PC, Barreto SM, Passos VM. Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health 2009; 9: 206.
21. Woloshin S, Schwartz LM, Welch HG. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 2008; 100: 845-53.
22. Katanoda K, Marugame T, Saika K et al. Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies. J Epidemiol 2008; 18: 251-64.
23. Jha P, Jacob B, Gajalakshmi V et al. A nationally representative case-control study of smoking and death in India. N Engl J Med 2008; 358: 1137-47.
24. Sitas F, Urban M, Bradshaw D, Kielkowski D, Bah S, Peto R. Tobacco attributable deaths in South Africa. Tob Control 2004; 13: 396-9.
25. Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R. Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol 2005; 34: 1395-402.
26. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40years' observations on male British doctors. BMJ 1994; 309: 901-11.
27. Rogot E, Murray JL. Smoking and causes of death among U.S. veterans: 16years of observation. Public Health Rep 1980; 95: 213-22.
28. Inoue Y, Koizumi A, Wada Y et al. Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC Study. J Epidemiol 2007; 17: 194-202.
29. Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-41.
30. Andrews J, Chandrasekaran P, McSwiggan D. Lower respiratory tract infections in an acute geriatric male ward: a one-year prospective surveillance. Gerontology 1984; 30: 290-6.
31. Garcia-Vidal C, Ardanuy C, Tubau F et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010;65:77-81.
32. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995; 8: 1694-8.
33. LaCroix AZ, Lipson S, Miles TP, White L. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 1989; 104: 350-60.
34. Madeddu G, Porqueddu EM, Cambosu F et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008; 36: 231-6.
35. Yende S, Angus DC, Ali IS et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 2007; 55: 518-25.
36. Garau J, Baquero F, Perez-Trallero E et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008; 14: 322-9.
37. Liu BQ, Peto R, Chen ZM et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998; 317: 1411-22.
38. Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R. Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. BMJ 2001; 323: 361.
39. Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003; 362: 507-15.
40. Slama K, Chiang CY, Enarson DA et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007; 11: 1049-61.
41. Leithead JA, Ferguson JW, Hayes PC. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl 2008; 14: 1159-64.
42. Pittet D, Thievent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993; 19: 265-72.
43. Arvanitidou M, Katikaridou E, Douboyas J, Tsakris A. Prognostic factors for nosocomial bacteraemia outcome: a prospective study in a Greek teaching hospital. J Hosp Infect 2005; 61: 219-24.
44. Huttunen R, Laine J, Lumio J, Vuento R, Syrjänen J. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect Dis 2007; 7: 13.
45. Bergstrom J, Floderus-Myrhed B. Co-twin control study of the relationship between smoking and some periodontal disease factors. Community Dent Oral Epidemiol 1983; 11: 113-6.
46. Bergstrom J, Eliasson S. Cigarette smoking and alveolar bone height in subjects with a high standard of oral hygiene. J Clin Periodontol 1987; 14: 466-9.
47. Bergstrom J, Eliasson S, Preber H. Cigarette smoking and periodontal bone loss. J Periodontol 1991; 62: 242-6.
48. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993; 64: 16-23.
49. Grossi SG, Genco RJ, Machtei EE et al. Assessment of risk for periodontal disease II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66: 23-9.
50. Martinez-Canut P, Lorca A, Magan R. Smoking and periodontal disease severity. J Clin Periodontol 1995; 22: 743-9.
51. Machuca G, Rosales I, Lacalle JR, Machuca C, Bullon P. Effect of cigarette smoking on periodontal status of healthy young adults. J Periodontol 2000; 71: 73-8.
52. Hyman JJ, Reid BC. Epidemiologic risk factors for periodontal attachment loss among adults in the United States. J Clin Periodontol 2003; 30: 230-7.
53. Bolin A, Eklund G, Frithiof L, Lavstedt S. The effect of changed smoking habits on marginal alveolar bone loss. A longitudinal study. Swed Dent J 1993; 17: 211-6.
54. Machtei EE, Dunford R, Hausmann E et al. Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol 1997; 24: 102-9.
55. Norderyd O, Hugoson A, Grusovin G. Risk of severe periodontal disease in a Swedish adult population. A longitudinal study. J Clin Periodontol 1999; 26: 608-15.
56. Bergstrom J, Eliasson S, Dock J. A 10-year prospective study of tobacco smoking and periodontal health. J Periodontol 2000; 71: 1338-47.
57. Renvert S, Dahlen G, Wikstrom M. The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. J Clin Periodontol 1998; 25: 153-7.
58. Apatzidou DA, Riggio MP, Kinane DF. Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. J Clin Periodontol 2005; 32: 973-83.
59. Bergstrom J, Eliasson S, Dock J. Exposure to tobacco smoking and periodontal health. J Clin Periodontol 2000; 27: 61-8.
60. Peivandi AA, Kasper-Konig W, Quinkenstein E, Loos AH, Dahm M. Risk factors influencing the outcome after surgical treatment of complicated deep sternal wound complications. Cardiovasc Surg 2003; 11: 207-12.
61. Sorensen LT, Hemmingsen U, Kallehave F et al. Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg 2005; 241: 654-8.
62. Nickelsen TN, Jorgensen T, Kronborg O. Lifestyle and 30-day complications to surgery for colorectal cancer. Acta Oncol 2005; 44: 218-23.
63. Folk JW, Starr AJ, Early JS. Early wound complications of operative treatment of calcaneus fractures: analysis of 190 fractures. J Orthop Trauma 1999; 13: 369-72.
64. Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002; 359: 114-7.
65. Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003; 238: 1-5.
66. Sorensen LT, Horby J, Friis E, Pilsgaard B, Jorgensen T. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002; 28: 815-20.
67. Siegel HJ, Patzakis MJ, Holtom PD, Sherman R, Shepherd L. Limb salvage for chronic tibial osteomyelitis: an outcomes study. J Trauma 2000; 48: 484-9.
68. Kark JD, Lebiush M. Smoking and epidemic influenza-like illness in female military recruits: a brief survey. Am J Public Health 1981; 71: 530-2.
69. Hanshaoworakul W, Simmerman JM, Narueponjirakul U et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS ONE 2009; 4: e6051.
70. Bensenor IM, Cook NR, Lee IM et al. Active and passive smoking and risk of colds in women. Ann Epidemiol 2001; 11: 225-31.
71. Aronson MD, Weiss ST, Ben RL, Komaroff AL. Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA 1982; 248: 181-3.
72. Gwaltney Jr JM, Hendley JO, Simon G, Jordan Jr WS. Rhinovirus infections in an industrial population II. Characteristics of illness and antibody response. JAMA 1967; 202: 494-500.
73. Furber AS, Maheswaran R, Newell JN, Carroll C. Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review Sex Transm Infect 2007; 83: 41-6.
74. Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. Aids 1993; 7: 705-10.
75. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. Aids 1996; 10: 1121-6.
76. Burns DN, Hillman D, Neaton JD et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 374-83.
77. Coates RA, Farewell VT, Raboud J et al. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 1990; 132: 717-22.
78. Eskild A, Petersen G. Cigarette smoking and drinking of alcohol are not associated with rapid progression to acquired immunodeficiency syndrome among homosexual men in Norway. Scand J Soc Med 1994; 22: 209-12.
79. Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 451-8.
80. Webber MP, Schoenbaum EE, Gourevitch MN, Buono D, Klein RS. A prospective study of HIV disease progression in female and male drug users. Aids 1999; 13: 257-62.
81. Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. Study Group for the MRC Collaborative Study of HIV Infection in Women. Sex Transm Infect 1999;75:247-52.
82. Burns DN, Kramer A, Yellin F et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr 1991; 4: 76-83.
83. Craib KJ, Schechter MT, Montaner JS et al. The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clin Invest Med 1992; 15: 301-8.
84. Miguez-Burbano MJ, Ashkin D, Rodriguez A et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 2005; 9: 208-17.
85. Feldman JG, Minkoff H, Schneider MF et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006; 96: 1060-5.
86. Cockerham L, Scherzer R, Zolopa A et al. Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era. J Acquir Immune Defic Syndr 2010; 53: 102-6.
87. Crothers K, Griffith TA, McGinnis KA et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005; 20: 1142-5.
88. Miguez-Burbano MJ, Burbano X, Ashkin D et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol 2003; 8: 39-43.
89. Mallat A, Hezode C, Lotersztajn S. Environmental factors as disease accelerators during chronic hepatitis C. J Hepatol 2008; 48: 657-65.
90. Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145: 1039-47.
91. Pessione F, Ramond MJ, Njapoum C et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001; 34: 121-5.
92. Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2006; 4: 797-801.
93. Hezode C, Lonjon I, Roudot-Thoraval F et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003; 52: 126-9.
94. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-5.
95. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 2006; 332: 1064-9.
96. Leandro G, Mangia A, Hui J et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006; 130: 1636-42.
97. Leake JA, Mosley DG, England B et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 2000; 181: 1435-40.
98. Rosenstein NE, Emery KW, Werner SB et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001; 32: 708-15.
99. Chuang YM, Ho YC, Chang HT, Yu CJ, Yang PC, Hsueh PR. Disseminated cryptococcosis in HIV-uninfected patients. Eur J Clin Microbiol Infect Dis 2008; 27: 307-10.
100. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004; 113: 1007-15.
101. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect 1994; 112: 315-28.
102. O'Dempsey TJ, McArdle TF, Morris J et al. A study of risk factors for pneumococcal disease among children in a rural area of west Africa. Int J Epidemiol 1996; 25: 885-93.
103. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax 1997; 52: 905-14.
104. Li JS, Peat JK, Xuan W, Berry G. Meta-analysis on the association between environmental tobacco smoke (ETS) exposure and the prevalence of lower respiratory tract infection in early childhood. Pediatr Pulmonol 1999; 27: 5-13.
105. Harlap S, Davies AM. Infant admissions to hospital and maternal smoking. Lancet 1974; 1: 529-32.
106. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Smoking. A Report of the Surgeon General. Rockville (MD):U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education. Office of Smoking and Health, 1986. DHHS Publication No. (CDC) 87-8398. 1986
107. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General-Executive Summary. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006. 2006.
108. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206-16.
109. Stampfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009; 9: 377-84.
110. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2: 372-7.
111. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29: 2303-9.
112. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003; 124: 1016-20.
113. Moss M, Parsons PE, Steinberg KP et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003; 31: 869-77.
114. O'Brien Jr JM, Lu B, Ali NA et al. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 2007; 35: 345-50.
115. Kyaw MH, Christie P, Clarke SC et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 2003; 37: 1283-91.
116. Kaech C, Elzi L, Sendi P et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006; 12: 345-52.
117. Blanco J, Muriel-Bombin A, Sagredo V et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008; 12: R158.
118. Royce RA, Winkelstein Jr W. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. Aids 1990; 4: 327-33.
119. Hirschtick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995; 333: 845-51.
120. Loeb M, Neupane B, Walter SD et al. Environmental risk factors for community-acquired pneumonia hospitalization in older adults. J Am Geriatr Soc 2009; 57: 1036-40.
121. Leung CC, Lam TH, Ho KS et al. Passive smoking and tuberculosis. Arch Intern Med 2010;170:287-92.
122. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994; 49: 825-34.
123. King Jr TE, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis 1988; 158: 1309-16.
124. Green GM, Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med 1967; 276: 421-7.
125. Stuart JM, Cartwright KA, Robinson PM, Noah ND. Effect of smoking on meningococcal carriage. Lancet 1989; 2: 723-5.
126. Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue oxygen. Arch Surg 1991; 126: 1131-4.
127. Jorgensen LN, Kallehave F, Christensen E, Siana JE, Gottrup F. Less collagen production in smokers. Surgery 1998; 123: 450-5.
128. Szarewski A, Maddox P, Royston P et al. The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. BJOG 2001; 108: 295-303.
129. Sasson IM, Haley NJ, Hoffmann D, Wynder EL, Hellberg D, Nilsson S. Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med 1985; 312: 315-6.
130. Stringer KA, Tobias M, O'Neill HC, Franklin CC. Cigarette smoke extract-induced suppression of caspase-3-like activity impairs human neutrophil phagocytosis. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1572-9.
131. Tollerud DJ, Clark JW, Brown LM et al. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis 1989; 139: 1446-51.
132. Nair MP, Kronfol ZA, Schwartz SA. Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes. Clin Immunol Immunopathol 1990; 54: 395-409.
133. Ferson M, Edwards A, Lind A, Milton GW, Hersey P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979; 23: 603-9.
134. Gualano RC, Hansen MJ, Vlahos R et al. Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir Res 2008; 9: 53.
135. Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol 2005; 6: 13.
136. Wang L, Joad JP, Zhong C, Pinkerton KE. Effects of environmental tobacco smoke exposure on pulmonary immune response in infant monkeys. J Allergy Clin Immunol 2008; 122: 400-6.